Dani Paul Bolognesi
Director Ejecutivo en B3 Bio, Inc. .
Cargos activos de Dani Paul Bolognesi
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
B3 Bio, Inc. | Director Ejecutivo | 10/09/2009 | - |
Presidente | 10/09/2009 | - | |
Fundador | 16/05/2011 | - | |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Director/Miembro de la Junta | 01/01/2016 | - |
Director Ejecutivo | 01/01/2016 | - | |
Senex Biotechnology, Inc.
Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC. | Director/Miembro de la Junta | - | - |
Historial de carrera de Dani Paul Bolognesi
Antiguos cargos conocidos de Dani Paul Bolognesi.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Director Técnico/Científico/I+D | 01/01/1993 | - |
Presidente | 01/01/1993 | - | |
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology InnAVasc Medical, Inc. designs and develops products for vascular access for hemodialysis. Its technology vascular access graft is designed to create one contiguous flow lumen without transition points. The company is headquartered in Durham, NC. | Director/Miembro de la Junta | - | - |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Director/Miembro de la Junta | 20/05/2009 | - |
Corporate Officer/Principal | - | - | |
Transgeneron Therapeutics, Inc.
Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transgeneron Therapeutics, Inc. researches and develops therapies to treat diseases. It develops therapeutic medicine that promotes tissue regeneration by reprogramming healthy tissue. This therapeutic reprogramming causes cells to 'trans-differentiate' into cells that can replace diseased or degenerated organs. The company was founded in April 2007 and is located in Gainesville, FL | Director/Miembro de la Junta | - | - |
Formación de Dani Paul Bolognesi.
Duke University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Director/Board Member | 5 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 6 |
---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Transgeneron Therapeutics, Inc.
Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transgeneron Therapeutics, Inc. researches and develops therapies to treat diseases. It develops therapeutic medicine that promotes tissue regeneration by reprogramming healthy tissue. This therapeutic reprogramming causes cells to 'trans-differentiate' into cells that can replace diseased or degenerated organs. The company was founded in April 2007 and is located in Gainesville, FL | Health Technology |
Senex Biotechnology, Inc.
Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC. | Health Technology |
B3 Bio, Inc. | |
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology InnAVasc Medical, Inc. designs and develops products for vascular access for hemodialysis. Its technology vascular access graft is designed to create one contiguous flow lumen without transition points. The company is headquartered in Durham, NC. | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Dani Paul Bolognesi
- Experiencia